Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.

@article{Nanri2016PrevalenceOA,
  title={Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.},
  author={Kazunori Nanri and Misaki Okuma and Saki Sato and Makoto Yoneda and Takeshi Taguchi and Hiroshi Mitoma and Junji Yamada and Sakae Unezaki and Tetsuo Nagatani and Shiho Otsubo and Mayumi Sugawara and Nobuyuki Tanaka and Hidehiro Mizusawa},
  journal={Internal medicine},
  year={2016},
  volume={55 5},
  pages={449-54}
}
OBJECTIVE Autoimmune cerebellar ataxias were recently reported to be treatable. However, the proportion of patients with cortical cerebellar atrophy of unknown etiology with autoimmune-associated cerebellar ataxia and the actual effectiveness of immunotherapy in these diseases remain unknown. METHODS We measured the level of autoantibodies (including anti-gliadin antibody, anti-glutamic acid decarboxylase (GAD) antibody, and anti-thyroid antibody) in 58 Japanese patients with cerebellar… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS